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Abstract
Background: Qualitative work has described the differences in prescribing practice across medical and surgical
specialties. This study aimed to understand if specialty impacts quantitative measures of prescribing practice.
Methods: We prospectively analysed the antibiotic prescribing across general medical and surgical teams for
acutely admitted patients. Over a 12-month period (June 2016 – May 2017) 659 patients (362 medical, 297 surgical)
were followed for the duration of their hospital stay. Antibiotic prescribing across these cohorts was assessed using
Chi-squared or Wilcoxon rank-sum, depending on normality of data. The t-test was used to compare age and
length of stay. A logistic regression model was used to predict escalation of antibiotic therapy.
Results: Surgical patients were younger (p < 0.001) with lower Charlson Comorbidity Index scores (p < 0.001).
Antibiotics were prescribed for 45% (162/362) medical and 55% (164/297) surgical patients. Microbiological results
were available for 26% (42/164) medical and 29% (48/162) surgical patients, of which 55% (23/42) and 48% (23/48)
were positive respectively. There was no difference in the spectrum of antibiotics prescribed between surgery and
medicine (p = 0.507). In surgery antibiotics were 1) prescribed more frequently (p = 0.001); 2) for longer (p = 0.016);
3) more likely to be escalated (p = 0.004); 4) less likely to be compliant with local policy (p < 0.001) than medicine.
Conclusions: Across both specialties, microbiology investigation results are not adequately used to diagnose
infections and optimise their management. There is significant variation in antibiotic decision-making (including
escalation patterns) between general surgical and medical teams. Antibiotic stewardship interventions targeting
surgical specialties need to go beyond surgical prophylaxis. It is critical to focus on of review the patients initiated
on therapeutic antibiotics in surgical specialties to ensure that escalation and continuation of therapy is justified.
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Background
Evidence suggests that a large proportion of antibiotic
prescribing in hospitals may be inappropriate [1–3].
Optimising antibiotic prescribing and reducing the use
of broad-spectrum agents has been shown to reduce the
occurrence of healthcare associated infections (HCAI) in
hospitals [4]. The bulk of antibiotic decision-making in
hospitals takes place with no direct input from infectious
disease or medical microbiology experts. There are many
branches of specialism in medical practice [5] with one
of the most important being between surgery and medi-
cine. The different cultures and team dynamics across
the medical and surgical specialties have been recently
described using qualitative methodology [6]. Evidence
suggests that antibiotic prescribing in surgery lacks
clarity and occurs in the context of disjointed informa-
tion [6, 7]. Studies from operating room practices have
highlighted how the environment and context can influ-
ence surgical outcomes [8]. In the case of surgical
prophylaxis, teams have reported that though aware of
guidelines and policy, they attribute a low priority to
policy adherence [9]. Whilst qualitative research is
critical for defining the context in which medical
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decision-making occurs across different specialties, and
describes how and why clinicians make antibiotic pre-
scribing decisions, it does not address what the effect of
these contextual differences are on clinical practice. In
this study we set out to investigate antibiotic prescribing
in medical and surgical specialties. Detailing and under-
standing the real-time clinical patterns of prescribing is
critical to the co- design of effective antibiotic optimisa-
tion interventions. Though the conditions for which
antibiotics are prescribed may differ across specialties,
the principles of infection diagnosis and management
are the same. This study set out to investigate whether
there was significant variation in the antibiotic prescrib-
ing practices between surgical and medical teams. This
knowledge is critical in order to shift from a one size fits
all approach to one that recognizes the specific challenges
facing clinicians treating infections across different
specialties.
Methods
Study sample size calculation
This study was conducted across general medical and
general surgical teams in one of the five hospitals of a
university affiliated Healthcare NHS Organisation, in
London. The hospital selected had the largest Emergency
Department (ED) and the highest annual turnover of
patients. The hospitals have an established, multidisciplin-
ary antimicrobial stewardship programme (ASP). Studies
across the hospitals have previously demonstrated a 10%
difference in compliance to the local antibiotic policy
between medical and surgical teams, with medical teams
demonstrating a higher rate of concordance [10].
A power calculation for two independent study groups
with a dichotomous primary endpoint was carried out
[11]. Using point prevalence data, anticipated incidence
of compliance to policy was estimated to be 83% in
surgery and 93% in medicine [10]. Setting the type one
error rate to 0.05, and type two error rate to 0.2, and
thus achieving a statistical power of 0.8, it was calculated
that the study would require 165 patients in each arm.
Exclusion and inclusion criteria
Between June 2016 – May 2017 adult patients (aged
≥18 years) admitted to the medical and surgical teams
and prescribed empiric antibiotics other than for
prophylaxis were eligible to be included in the study.
Data were collected from each ward on alternate weeks.
Patients were prospectively identified on qualitative ob-
servations of acute ward rounds as part of a mixed
methods study [6, 7]. Patients with a hospital stay less
than 24 h, and those from (or transferred to) other spe-
cialties were excluded.
Data collection
This study had a prospective cohort design. The ref-
erence group were the medical cohort and the com-
parison group were the surgical cohort. An accurate
assessment of the appropriateness of the prescribed
antibiotics requires real-time infectious diseases
consultations in parallel to the care provided by the
respective teams. In the absence of being able to
measure appropriateness, the primary outcome mea-
sures selected in this study were compliance to the
local antibiotic policy, and changes to antibiotic pre-
scriptions (e.g. escalation or de-escalation). The sec-
ondary outcome measures were, duration of antibiotic
prescriptions, length of hospital stay, use of micro-
biology and radiology to guide therapy, and 30-day
readmission. Patient demographics, antibiotic prescrip-
tions and corresponding indications, and inflamma-
tory marker results were obtained from the patient
notes. One researcher (EC) collected all the data. A
single reading of white cell count, C-reactive protein,
and temperature, closest to the time of initiating anti-
biotic therapy were recorded. Procalcitonin is not rou-
tinely tested for patients in this hospital. The International
Classification of Diseases, tenth revision (ICD-10) coding
was used to calculate the age-adjusted Charlson comorbidity
index (ACCI) for subjects [12]. Comorbidity was ranked by
using the final CCI. The CCI score was ranked as: a) 0–2
low; b) 3–4 moderate; and c) 5 or above, severe [13].
The antibiotic exposure days were measured as the
number of days that a patient received one or more
systemic antibiotics. The cumulative antibiotics days,
where multiple antibiotics prescribed on the same day
were counted as multiple antibiotic days, was also
measured. Cumulative antibiotic exposure days has been
used previously [14], regarding its association with
Clostridium difficile infection.
Antibiotics were ranked in ascending order accord-
ing to their relative activity against drug-resistant or-
ganisms [15](Table 1).
Changes made to prescribed antibiotics were classified,
using published criteria [16]. Escalation of therapy was
defined as the switch to or addition of an agent with a
broader spectrum, or additional coverage, or switch from
oral to intravenous therapy. De-escalation of therapy
was defined as stopping therapy, or de-escalation from
intravenous to oral, or changing to an agent with a less
broad-spectrum coverage. If antibiotic choice was re-
stricted or changed to broad spectrum agents due to an
allergy to a class or individual antibiotic(s), the therapy
was classified as unchanged e.g. not de-escalated or
escalated.
The following criteria were used to assess whether
the antibiotics prescribed were compliant with local
empiric policy:
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 Was the indication documented on the electronic
chart or the medical notes?
 Did the indication have a matching
recommendation in the policy?
 If there was no recommendation in the policy, was
there any infection team input?
For cases where the indication was missing or vague
e.g. ‘for infection’, this variable was labelled as unclear.
The reason for having an unclear category as opposed to
missing data was to identify cases where the antibiotic
prescription had been prescribed and no indication
recorded in the notes or the medication chart. One of
the requirements of the policy is that for all therapeutic
courses of antibiotics, there should be an indication
recorded. If antibiotic therapy did not match the recom-
mendation in the policy for the recorded indication, and
there was no infection team input, it was labelled as
non-compliant.
Data analysis
The analysis was carried out using Stata, (StataCorp,
College Station, Texas, US) version 13.1. Variation in the
descriptive variables between the cohorts was assessed
using Chi- squared or Wilcoxon rank-sum, depending
on normality of data. An independent t-test was used to
determine if there were statistical differences in the age
and length of stay of patients in the cohorts. We created
a logistic regression model to understand the predictors
of antibiotic prescribing (as measured by escalation) and
see whether there were differences between the two
groups after adjusting for these. Escalation was the
measure used in the model as deviations from policy can
often have a legitimate reason, and hence compliance to
policy was not deemed an appropriate measure of the
quality of antibiotic prescribing. The variables specialty,
length of stay, ACCI, positive chest X-ray and microbio-
logical results were selected as predictors based on exist-
ing literature and discussions with the clinicians [6]. The
length of stay, antibiotic exposure days, and the comor-
bidity index were fitted as categorical variables in the
model, as they were skewed in their distributions. Statis-
tical significance was defined as a p ≤ 0.05. The length of
stay and ACCI were tested in the regression model as
both continuous and categorical variables. In both cases,
the scaling (i.e. variable) type with the best fit was




All subjects had complete data for the variables included
in this study. The teams admitted 659 patients (362 in
medicine and 297 in surgery) during the study period
(Fig. 1). One surgical and 6 medical patients were
excluded from the statistical analysis in this study (reasons
detailed in Fig. 1). Of the included patients, 162 (45%) in
medicine, and 164 (55%) in surgery were receiving at least
one course of therapeutic antibiotics. During the ward
rounds observed in the study, prescribed antibiotics were
reviewed in 143/162 (88%) of medical and 111/164 (68%)
of surgical patients.
At the time of initiating antibiotics, a normal white cell
count was present in 76/162 (47%) of medical, and 52/
164 (32%) of surgical patients (Table 2). Antibiotics were
started in the absence of a) fever and b) abnormal white
blood cell count in 32/162 (19%) of medical and 32/164
(19%) of surgical patients. C-reactive protein was re-
corded as high, or rising in 308/326 (95%) patients
across both specialties. Radiological data in the form of
chest x-ray, was available for 90/162 (55%) medical and
in 64/164 (39%) surgical patients. In medicine, 36/162
(22%), and in surgery 17/164 (10%) patients had infec-
tion confirmed in the radiological report accompanying
the chest X-ray. Of all the patients receiving antibiotics
23/162 (14%) in medicine and 23/164 (14%) in surgery
had a positive microbiological sample.
There were 395 antibiotic prescriptions in medicine
and 461 in surgery. These included the same antibiotic
given by a different route or on different occasions to
the same patient in the same admission spell. Of the
prescribed antibiotic courses, 200/395 (51%) of medical,
and 395/461 (86%) surgical were intravenous. Over half,
90/162 (56%) of medical patients were initiated on anti-
biotics for a respiratory infection (Table 3). Urinary tract
infections were the second most common indication in
medical patients (29/162; 18%). In surgery, intraperitoneal
infections e.g. diverticulitis and appendicitis, were the
most common indication (44/164; 27%), followed by bil-
iary infections e.g. cholecystitis (39/164; 24%). Antibiotics
Table 1 Antibiotic ranking
Rank 1 Narrow spectrum, including first-generation and second –generation cephalosporins,
amoxicillin, co-trimoxazole, metronidazole, and oral vancomycin;
Rank 2 Broad spectrum, including flouroquinolones, macrolides, third-generation cephalosporins,
co-amoxiclav, clindamycin;
Rank 3 Extended spectrum, including antipseudomonal penicillins, antipseudomonal carbapenems
and intravenous vancomycin;
Rank 4 Restricted, including colistin, tigecycline, linezolid, and daptomycin
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were initiated for suspected sepsis in 14/164 (9%) surgical
and 5/162 (3%) medical patients. There was no statistically
significant difference (p = 0.507) in the spectrum and rank
of antibiotics that the medical and surgical patients were
exposed to during their stay.
The mean length of stay was 11 days (±1.21) in medi-
cine, 16 days (±1.87) in surgery, t (324), p = 0.0553
(Table 3). Medical patients had a significantly higher CCI
score (p < 0.001). Thirty-day readmission to hospital was
significantly higher in medicine versus surgery (p < 0.001).
There was no difference (p = 0.977) in mortality during the
admission episode in the two groups. Monotherapy, was
more likely (p < 0.001) in medicine than surgery, with 36/
162 (22%) vs. 12/164 (7%), of patients being treated with
one course of antibiotics during their stay, respectively
(Table 4). Surgical patients had 50/164 (30%) cumulative
antibiotics days equal to or greater than 15, compared with
22/162 (15%) medical patients (p = 0.016). Escalation of the
initial antibiotic therapy was more likely in the surgical
patients than in medical patients, with 49/164 (30%) ther-
apy escalations in surgery compared with 31/162 (19%) in
medicine (p = 0.0037).
The lack of a documented indication for prescribed
antibiotics made it difficult to assess the compliance to
policy for 21/164 (13%) patients in surgery. When in-
cluded as a three-category variable (Yes/No/Unclear) there
was a statistically significant difference (p < 0.001) in com-
pliance to policy between medicine (131/162, 80.86) and
surgery (108/164, 65.85) (Table 5). In addition to receiving
antibiotics during their stay, 80/162 (49%) medical and 73/
164 (45%) surgical patients were subsequently discharged
home with a course of antibiotics.
In the logistic regression model, the unadjusted odds
ratio of therapy escalation in surgery versus medicine
was 1.801, 95% CI 1.071–3.028, P = 0.024. In surgery,
64/164 (39%) of patients underwent an operation during
their stay. Having an operation (reference set as not hav-
ing an operation) was associated with increased odds of
escalation of antibiotic therapy (OR = 1.69, 95% CI
0.939–3.042, p = 0.082) in the surgical cohort, although
this was not statistically significant. In the fully adjusted
logistic regression model the odds ratio of antibiotic
therapy escalation in surgical patients remained signifi-
cantly higher compared to medicine (OR = 1.94, 95% CI:
1.07–3.53, p = 0.03). Comorbidity, culture and sensitivity
results and signs of infection on chest X-ray did not sig-
nificantly affect the odds of therapy escalation in the re-
gression model. There was a statistically significant
association between length of stay and escalation of ther-
apy (Table 6).
Discussion
In this study we investigated real-time antibiotic prescrib-
ing practices in surgical and medical teams, in order to
understand the variation in practice and identify the
current gaps. This understanding of the variation in prac-
tice across the specialties and teams is necessary, in order
to develop bespoke stewardship interventions that target
the gaps in practice within specialties. Half the patients
received at least one course of antibiotics during their hos-
pital stay. Surgical patients were more likely to receive
multiple courses of antibiotics during their hospital stay,
and were less likely to have their antibiotic therapy
reviewed during ward rounds. The propensity in surgery
Fig. 1 Flow diagram of sample derivation for inclusion in the study
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in this study was to initially prescribe cefuroxime and
metronidazole and then step up to intravenous broad-
spectrum agents e.g. piperacillin/ tazobactam, and co-
amoxiclav with addition of other agents such as gentami-
cin and vancomycin. In medicine, broad-spectrum agents
were more likely to be initiated upon admission and the
focus stewardship efforts should be in the initial phase of
the patients’ hospital stay. Over the course of the hospital
stay however, this study found no statistical difference
between the spectrum of antibiotics prescribed in surgery
and medicine. This is a new and valuable finding as in sur-
gery, most ASP interventions target surgical prophylaxis
or surgical site infection prevention [17, 18]. In surgery
stewardship efforts should be focused on patients who re-
main in hospital in the post-operative phase where they
are likely to be initiated on broad spectrum antibiotics.
Diagnostic tests, though available were not routinely
used to rationalise antibiotic prescribing. Two of the key
interventions in optimising antibiotic use are obtaining a
microbiological culture prior to initiation of antibiotic
therapy and ensuring relevant imaging [4, 19]. One in
five of the patients in both specialties were initiated on
antibiotics in the absence of fever and raised white cell
count, and culture and sensitivity data were only col-
lected from one third of patients initiated on antibiotics.
These findings are consistent with studies reporting
Table 2 Relative frequency of diagnostic information for patients started on antibiotics in medicine, and surgery (normal ranges are
those defined in the local laboratory)
Diagnostic Information Total 326 n (%) Medicine 162 n (%) Surgery 164 n (%)
White Cell Count
Normal (4.2–11.2 × 109/L) 128 (39.3) 76 (47.0) 52 (31.7)
Abnormal 197 (60.4) 86 (53.0) 111 (68.1)
No Data 1 (0.3) 0 1 (0.6)
Body Temperature
Normal (36.5–37.5 °C) 168 (51.5) 70 (43.2) 98 (60.0)
Abnormal 157 (48.2) 91 (56.2) 66 (40.0)
No Data 1 (0.3) 1 (0.6) 0
Body temperature and White Cell Count
Normal 64 (19.4) 32 (19.4) 32 (19.4)
Abnormal 260 (80.0) 129 (80.0) 131(80.0)
No Data 2 (0.6) 1 (0.6) 1 (0.6)
C-reactive Protein
Normal (< 6 mg/L) 17 (5.2) 11 (7.0) 6 (3.7)
Abnormal (> 6 mg/L) 308 (94.5) 151 (93.0) 157 (95.7)
No Data 1 (0.3) 0 1 (0.6)
Chest X-ray at start of antibiotic
Yes 154 (47.0) 90 (55.6) 64 (39.0)
No 172 (53.0) 72 (44.4) 100 (61.0)
Sign of infection on chest X-ray
Yes 53 (16.0) 36 (22.0) 17 (10.0)
No 101 (31.0) 54 (33.3) 47 (29.0)
No imaging 172 (53.0) 72 (44.4) 100 (61.0)
Microbiological culture collected
before antibiotic initiation
Yes 90 (27.6) 42 (26.0) 48 (29.0)
No 236 (72.4) 120 (74.0) 116 (71.0)
The result of microbiological culture
collected before antibiotic initiation
No growth (negative culture) 44 (13.5) 19 (11.7) 25 (15.0)
Pathogen grown (positive culture) 46 (14.1) 23 (14.2) 23 (14.0)
No Culture 236 (72.4) 120 (74.1) 116 (71.0)
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inappropriate antibiotic use in hospitals and the inad-
equate use of available diagnostic tests [15, 20–22]. Iden-
tifying the causative organism for the infection, through
use of laboratory diagnostics, has been shown to be
highly effective in optimising antibiotic therapy [23, 24].
Over 95% of all patients across medicine and surgery
had a raised C-reactive protein level at initiation of anti-
biotic therapy. Published studies have described the role of
C-reactive protein in the diagnosis of infections [25, 26], in
particular its overuse post-operatively. In post-operative
patients C-reactive protein levels can become elevated [26]
in response to the trauma of the surgery, and as such the
utility of using this marker as a specific marker of infection
is inappropriate. Likewise, in medicine the level may be
raised due to acute conditions other than infection, such as
a myocardial infarct [27–29]. In clinical practice, it is not
the absolute C-reactive protein level that should be used,
but its trend over time. Large studies on the response of C-
reactive protein to antibiotic therapy in infections are lack-
ing [30]. Much work is needed to shift the attitude of
healthcare professionals away from their dependency to use
C-reactive protein elevation to initiate antibiotics. Clinicians
should be encouraged to use their clinical skills for diagnos-
ing infections and to consult with the available pharmacy
and infection specialists. Failing that, the routine use of C-
reactive protein as a diagnostic marker should be limited.
The surgical patients were primarily receiving intra-
venous antibiotics. As most of the caseload was intra-ab-
dominal infections the intravenous route is entirely
acceptable, especially in patients who have had an oper-
ation, and who may have poor gut absorption. Despite
these dispensations, only 40% of the surgical patients
underwent an operation, however 86% of the antibiotic
courses in surgery were intravenous. It would be valuable
to repeat this study amongst different surgical specialties
to see if the use of intravenous route is as prevalent across
the different disciplines in surgery. This study found an
association between increased length of stay and antibiotic
escalation. Several studies have demonstrated an associ-
ation between reduced length of hospital stay and de-
Table 3 Indication for empiric antibiotic course by specialty (* included non-defined infections in surgery and of various organ
systems in medicine)
Indication for antibiotic therapy Total 326 n (%) Medicine 162 n (%) Surgery 164 n (%)
Respiratory 104 (31.90) 90 (55.56) 14 (8.54)
Urinary tract 39 (11.96) 29 (17.90) 10 (6.10)
Intraperitoneal/ Gastrointestinal 48 (14.72) 4 (2.47) 44 (26.83)
Skin and soft tissue 16 (4.91) 8 (4.94) 8 (4.88)
Sepsis 19 (5.83) 5 (3.09) 14 (8.54)
Biliary 39 (11.96) 0 39 (23.78)
Other* 61 (18.71) 26 (16.05) 35 (21.34)
Table 4 Univariable analysis of demographic outcomes by specialty
Variable Measure Medicine N = 162 Surgery N = 164 P value*
Gender - Male n (%) 76 (47) 84 (51) 0.441
Age at admission Mean (SD) 70 (18) 55 (22) –
Median (Interquartile range) 74 (27–93) 55 (18–92) < 0.001
Range (Minimum – Maximum) 21–104 18–95 –
Length of Stay Mean (SD) 11 (15) 16 (24) 0.0553
Median (Interquartile range) 7 (1–76) 5 (2–106) < 0.001




Low (score of 0–2) 30 (19) 89 (54) < 0.001
Moderate (score of 3–4) 39 (24) 23 (14)
Severe (score of ≥5) 93 (57) 52 (32)
30 day readmission n (%) 43 (27) 29 (18) < 0.001
Mortality in admission episode n (%) 10 (6) 10 (6) 0.977
Abbreviations: n count, SD standard deviation
*P values calculated using Pearson Chi-Squared test or t-test where appropriate.
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escalation of antibiotic use, suggesting that de-escalation
can lead to reduced length of stay [31, 32]. The reverse
can also be expected, that patients who have their anti-
biotic therapy escalated can be more ill and therefore in
need of remaining in hospital. Antibiotic prescribing in
the surgical team was also more likely to be non-com-
plaint to local policy and guidelines. The medical specialty
were more consistent in providing a rationale and indica-
tion for prescribed antibiotics. Including the unclear cat-
egory in the analysis was important to illustrate the lack of
documented indication for antibiotic therapy in surgery.
The local policy stipulates that an indication must be doc-
umented for prescribed antibiotics. A missing indication
could also be classed as inappropriate and therefore non-
Table 5 Univariable analysis of antibiotic related variables by specialty
Medicine 162 n (%) Surgery 164 n (%) p value *
Total number of courses of antibiotics 395 461 –
Route of antibiotics (as a total of all courses)
Intravenous 200 (51) 395 (86) < 0.001
Oral 195(49) 66 (14)
Number of antibiotics during spell
1 36 (22.22) 12 (7.32) 0.001
2 52 (32.10) 68 (41.46)
≥ 3 74 (45.68) 84 (51.22)
Antibiotic exposure days
1–3 days 65 (40) 56 (34) 0.134
4–7 days 55 (34) 52 (32)
7–14 days 28 (17) 33 (20)
≥ 15 14 (9) 23 (14)
Cumulative antibiotic days
1–7 days 94 (58) 70 (43) 0.016
8–14 days 46 (28) 44 (27)
≥ 15 22 (14) 50 (30)
Antibiotic rank
Narrow 11(6.79) 6 (3.66) 0.507
Broad 98 (60.49) 95 (57.93)
Extended 47 (29.00) 56 (34.15)
Restricted 6 (3.70) 7 (4.27)
Change to initial antibiotic course
No change/discontinued 76 (46.91) 90 (54.88) 0.0037
Antibiotic escalated 31 (19.14) 49 (29.88)
Antibiotic de-escalated 55(33.95) 25 (15.24)
Antibiotic compliant to local policy
Yes 131 (80.86) 108 (65.85) < 0.001
No 30 (18.52) 35 (21.34)
Unclear 1 (0.62) 21 (12.80)
Antibiotic compliant to local policy (‘unclear’ treated as missing)
Yes 131 (81.37) 108 (75.52) 0.215
No 30 (18.63) 35 (24.48)
Antibiotic prescribed on discharge
Yes 80 (49) 73 (45) 0.677
No 67 (41) 74 (45)
No data/Patient died 15 (9) 17 (10)
*P values calculated using Pearson Chi-Squared test or Fisher’s exact test
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compliant to the local policy. Including the ‘unclear’ cat-
egory in the analysis accommodated for this deviation
from policy.
This study was conducted alongside an in-depth qualita-
tive ethnographic research that described the contextual
differences in decision-making between the teams [6, 7]
and identified key differences in how these teams prioritise
antibiotic decision-making. The qualitative research re-
ported a model of individualism in surgery, where sur-
geons driven by performance metrics, are less willing to
tolerate uncertainty in antibiotic decision-making [6]. The
qualitative findings add value and provide contextual
insights to better understand the quantitatively measured
antibiotic decision-making behaviours, describe in this
cohort study. Practicing a defensive prescribing approach
in surgery, and less comfortable with uncertainty in the
decisions made for the patients, surgeons may try to avert
the risk of a patient developing infections by prescribing
broad-spectrum antibiotics. Additionally, the qualitative
findings identified the surgical teams to be willing to dele-
gate antibiotic decision-making to the junior staff or other
specialties [6, 7]. This can be leveraged to develop better
collaborations between stewardship and surgical teams to
ensure that antibiotic prescribing in surgery can be
optimised.
There are several key recommendations from this
study that can be used to develop bespoke stewardship
interventions. Antibiotic stewardship interventions in
surgery should focus on the post-operative period or in
patients who are under surgical care for longer dura-
tions, as they are more likely to be on more broad-
spectrum antibiotics and to receive multiple courses.
Across both specialties more focus needs to be placed
on ensuring the correct microbiology tests are per-
formed prior to initiating antibiotic therapy. This can
help support correct diagnosis earlier in medial patients
to a more targeted spectrum of therapies, and in surgical
patients in can help teams with being able to correctly
diagnose infections and provide an indication for the
prescribed antibiotics.
Limitations
This is a single-center study focusing on two general
medical and surgical teams. The data may therefore not
Table 6 Multiple logistic regression examining the association between escalating antibiotic therapy and the selected variables,
adjusting for specialty (n = 326)




Surgery 1.801 1.076–3.013 0.024 1.942 1.067–3.534 0.030
Comorbidity score
Low 1 1
Mod 1.164 0.629 – 0.629 0.845 0.402–1.773 0.655
Severe 1.380 2.151
0.741–2.570
0.310 1.123 0.541–2.354 0.747
Culture and sensitivity
Negative 1 1
Positive 0.569 0.236 – 0.209 0.583 0.218–1.559 0.282
No culture 0.378 1.371
0.192–0.746
0.005 0.470 0.219–1.009 0.053
Los
1–7 1 1
8–14 2.027 0.998 – 0.051 2.012 0.962–4.215 0.064
≥ 15 5.758 4.117
3.137–10.567
< 0.001 5.138 2.66–9.910 < 0.001
Sign of infection on chest X-ray
No 1 1
Yes 1.145 0.563 – 0.709 1.405 0.635–3.109 0.402
No chest X-ray 0.486 2.323
0.273–0.863
0.014 0.610 0.328–1.173 0.142
a Adjusted for all other variables included within this table
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be representative of the breadth of hospital specialties.
The cohorts of general medicine and surgery may not be
comparable in terms of infection etiology. To address
this, one of the primary outcome measures was compli-
ance to policy. This adjusted for the variation between
the cohorts, as regardless of the cause of infection the
antibiotic therapy would be expected to the compliant to
the local policy recommendation for the indication.
Since the sample size required to address the research
questions was small it was not feasible to include a
broad number of infections in the analysis. The inaccur-
acies of ICD-10 coding have been reported [33]. Any
inaccuracies in the coding will have an impact on the
ACCI score derived for the patients in this study. For
the multivariate regression analysis performed, inde-
pendent variables that were not available through the
data collection methods used, such as infection markers
at end of antibiotic therapy could affect prescribing out-
comes that were not included in this model. The afore-
mentioned model only includes chest X-ray as a radiological
measure. If all the forms of potential diagnostic tests were
included, there would be too many categories to consider,
for which missing data would be high across different infec-
tion-types, and therefore we utilized the most commonly
performed diagnostic test.
Conclusion
One in five patients (across surgery and medicine) were
prescribed antibiotics in the absence of raised white cell
count or a fever. There is no difference in the spectrum
of antibiotics prescribed between medicine and surgery.
Surgical patients are significantly more likely to a) re-
ceive a greater number of courses of antibiotics; b) have
their initial therapy escalated; and c) be on a course not
in line with local policy. There are opportunities to
widen the reach of ASP and focus on perioperative care,
focusing on the review of antibiotic prescriptions in the
post-operative phase.
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